{"id":2403,"date":"2026-04-10T08:27:59","date_gmt":"2026-04-10T05:27:59","guid":{"rendered":"https:\/\/merkezlaboratuvari.com\/test-listesi\/ldh-laktat-dehidrogenaz-bos-2\/"},"modified":"2026-04-21T12:38:28","modified_gmt":"2026-04-21T09:38:28","slug":"ldh-laktat-dehidrogenaz-bos","status":"publish","type":"page","link":"https:\/\/merkezlaboratuvari.com\/ar\/test-listesi\/ldh-laktat-dehidrogenaz-bos\/","title":{"rendered":"LDH (Laktat Dehidrogenaz), BOS"},"content":{"rendered":"<h1>LDH (Laktat Dehidrogenaz), BOS<\/h1>\n<h2>Laboratuvar Bilgileri<\/h2>\n<ul>\n<li><strong>Yeni Kod:<\/strong> BIO2389<\/li>\n<li><strong>SUT Kodu:<\/strong> L104930<\/li>\n<li><strong>Eski Kod:<\/strong> B\u01300233<\/li>\n<li><strong>Kategori:<\/strong> \u0643\u064a\u0645\u064a\u0627\u0621 \u062d\u064a\u0648\u064a\u0629<\/li>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> BOS<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Steril Kap<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:01<\/li>\n<\/ul>\n<h2>LDH (Laktat Dehidrogenaz), BOS Testi Nedir?<\/h2>\n<p>LDH (Laktat Dehidrogenaz), BOS, laboratuvar ortam\u0131nda de\u011ferlendirilen bir biyokimya testidir. De\u011ferlendirme \u00e7o\u011fu zaman bos \u00f6rne\u011fi \u00fczerinden planlan\u0131r.<\/p>\n<p>LDH (Laktat Dehidrogenaz), hemen hemen t\u00fcm v\u00fccut dokular\u0131nda bulunan bir h\u00fccre i\u00e7i enzimdir. Glikoliz ve glukoneogenez yolaklar\u0131nda laktat ile piruvat aras\u0131ndaki d\u00f6n\u00fc\u015f\u00fcm\u00fc katalize eder. Doku hasar\u0131 veya h\u00fccre y\u0131k\u0131m\u0131 oldu\u011funda kana sal\u0131n\u0131r. Be\u015f izoenzim formu vard\u0131r (LDH-1 ila LDH-5), her biri farkl\u0131 dokularda bask\u0131nd\u0131r.<\/p>\n<p>Bu testin klinik anlam\u0131; istem nedeni, hastan\u0131n yak\u0131nmalar\u0131, ya\u015f\u0131, e\u015flik eden hastal\u0131klar\u0131, kullan\u0131lan y\u00f6ntem ve di\u011fer laboratuvar bulgular\u0131 ile birlikte de\u011ferlendirilir. Bu nedenle sonu\u00e7, tek ba\u015f\u0131na de\u011fil, b\u00fct\u00fcnc\u00fcl t\u0131bbi \u00e7er\u00e7eve i\u00e7inde yorumlanmal\u0131d\u0131r.<\/p>\n<h2>LDH (Laktat Dehidrogenaz), BOS Hangi Durumlarda \u0130stenir?<\/h2>\n<p>LDH (Laktat Dehidrogenaz), BOS testi, hekim taraf\u0131ndan klinik gereklilik g\u00f6r\u00fclen durumlarda istenebilir. \u0130stem gerek\u00e7esi hastan\u0131n mevcut tablosuna g\u00f6re de\u011fi\u015febilir.<\/p>\n<ul>\n<li>Hemolitik anemilerin tan\u0131 ve takibi<\/li>\n<li>Malign hastal\u0131klar\u0131n (lenfoma, l\u00f6semi, germ h\u00fccreli t\u00fcm\u00f6rler) izlemi ve prognozu<\/li>\n<li>Miyokard enfarkt\u00fcs\u00fc de\u011ferlendirmesi (g\u00fcn\u00fcm\u00fczde troponin tercih edilir)<\/li>\n<li>Pulmoner emboli \u015f\u00fcphesi<\/li>\n<li>Karaci\u011fer hastal\u0131klar\u0131<\/li>\n<li>Megaloblastik anemi (B12\/folat eksikli\u011fi)<\/li>\n<li>T\u00fcm\u00f6r lizis sendromu takibi<\/li>\n<li>Kas hastal\u0131klar\u0131<\/li>\n<li>\u0130nfeksiy\u00f6z monon\u00fckleoz<\/li>\n<\/ul>\n<p>Ayn\u0131 test farkl\u0131 hastalarda farkl\u0131 klinik sorulara yan\u0131t aramak amac\u0131yla kullan\u0131labildi\u011fi i\u00e7in, nihai de\u011ferlendirme her zaman ki\u015fisel t\u0131bbi \u00f6yk\u00fc ve muayene bulgular\u0131 ile birlikte yap\u0131lmal\u0131d\u0131r.<\/p>\n<h2>LDH (Laktat Dehidrogenaz), BOS Testi \u00d6ncesi Haz\u0131rl\u0131k<\/h2>\n<p>Haz\u0131rl\u0131k gereksinimi; testin t\u00fcr\u00fcne, numune yap\u0131s\u0131na ve laboratuvar\u0131n \u00e7al\u0131\u015fma kurallar\u0131na g\u00f6re de\u011fi\u015febilir. Test \u00f6ncesinde laboratuvar\u0131n ve hekimin verdi\u011fi talimatlar esas al\u0131nmal\u0131d\u0131r.<\/p>\n<ul>\n<li>A\u00e7l\u0131k genellikle gerekmez.<\/li>\n<li>A\u011f\u0131r fiziksel aktiviteden testten 24 saat \u00f6nce ka\u00e7\u0131n\u0131lmal\u0131d\u0131r.<\/li>\n<li>Hemolizli numunelerden ka\u00e7\u0131n\u0131lmal\u0131d\u0131r (eritrositlerde y\u00fcksek LDH bulunur).<\/li>\n<\/ul>\n<p>Kullan\u0131lan ila\u00e7lar, takviyeler, yak\u0131n d\u00f6nemde ge\u00e7irilen hastal\u0131klar ve e\u015flik eden kronik durumlar sonucun yorumlanmas\u0131n\u0131 etkileyebilece\u011fi i\u00e7in sa\u011fl\u0131k profesyoneli ile payla\u015f\u0131lmal\u0131d\u0131r.<\/p>\n<h2>LDH (Laktat Dehidrogenaz), BOS Testi Nas\u0131l Yap\u0131l\u0131r?<\/h2>\n<p>LDH (Laktat Dehidrogenaz), BOS testi, uygun biyolojik \u00f6rnek al\u0131nd\u0131ktan sonra laboratuvar\u0131n belirledi\u011fi y\u00f6ntemle \u00e7al\u0131\u015f\u0131l\u0131r. Numunenin do\u011fru zamanda, uygun kapta ve uygun ta\u015f\u0131ma ko\u015fullar\u0131nda ula\u015ft\u0131r\u0131lmas\u0131 test kalitesi a\u00e7\u0131s\u0131ndan \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li><strong>Numune T\u00fcr\u00fc:<\/strong> BOS<\/li>\n<li><strong>Numune Kab\u0131:<\/strong> Steril Kap<\/li>\n<li><strong>\u00c7al\u0131\u015fma G\u00fcn\u00fc:<\/strong> Her g\u00fcn<\/li>\n<li><strong>\u00d6nemli Kriter:<\/strong> \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.<\/li>\n<li><strong>Raporlama Tarihi:<\/strong> Ayn\u0131 g\u00fcn 18:01<\/li>\n<\/ul>\n<ul>\n<li><strong>Numune tipi:<\/strong> Ven\u00f6z kan (serum)<\/li>\n<li><strong>Numune al\u0131m\u0131:<\/strong> Koldan ven\u00f6z kan al\u0131n\u0131r; hemolizden ka\u00e7\u0131n\u0131lmal\u0131d\u0131r.<\/li>\n<li><strong>Y\u00f6ntem:<\/strong> Kinetik UV y\u00f6ntemi (laktat \u2192 piruvat veya piruvat \u2192 laktat y\u00f6n\u00fc)<\/li>\n<li><strong>Sonu\u00e7 s\u00fcresi:<\/strong> Genellikle ayn\u0131 g\u00fcn i\u00e7inde sonu\u00e7lan\u0131r.<\/li>\n<\/ul>\n<p>Baz\u0131 durumlarda \u00f6rnek kalitesi, numune miktar\u0131, ta\u015f\u0131ma s\u00fcresi veya teknik tekrar gereksinimi raporlama s\u00fcresini ve sonucun g\u00fcvenilirli\u011fini etkileyebilir.<\/p>\n<h2>LDH (Laktat Dehidrogenaz), BOS Testi Ka\u00e7 G\u00fcnde \u00c7\u0131kar?<\/h2>\n<p>Mevcut laboratuvar bilgisine g\u00f6re bu test i\u00e7in raporlama s\u00fcresi: <strong>Ayn\u0131 g\u00fcn 18:01<\/strong> \u015feklindedir.<\/p>\n<p>Numunenin kabul zaman\u0131, laboratuvar\u0131n \u00e7al\u0131\u015fma plan\u0131, resmi tatiller veya gerekti\u011finde tekrar \u00e7al\u0131\u015fma gibi etkenler sonucu etkileyebilece\u011fi i\u00e7in en g\u00fcncel bilgi rapor tarihi \u00fczerinden de\u011ferlendirilmelidir.<\/p>\n<h2>Referans De\u011ferleri ve Sonu\u00e7lar\u0131n De\u011ferlendirilmesi<\/h2>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Grup<\/th><th>De\u011fer Aral\u0131\u011f\u0131<\/th><\/tr><\/thead><tbody><tr><td>Yeti\u015fkin<\/td><td>120\u2013246 U\/L<\/td><\/tr><tr><td>Yenido\u011fan<\/td><td>160\u2013450 U\/L<\/td><\/tr><tr><td>\u00c7ocuk (1\u201314 ya\u015f)<\/td><td>150\u2013300 U\/L (ya\u015fla birlikte azal\u0131r)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<h3>LDH \u0130zoenzimleri<\/h3>\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>\u0130zoenzim<\/th><th>Ba\u015fl\u0131ca Kaynak<\/th><\/tr><\/thead><tbody><tr><td>LDH-1<\/td><td>Kalp, eritrositler<\/td><\/tr><tr><td>LDH-2<\/td><td>Retik\u00fcloendotelyal sistem<\/td><\/tr><tr><td>LDH-3<\/td><td>Akci\u011fer, trombositler, lenfositler<\/td><\/tr><tr><td>LDH-4<\/td><td>B\u00f6brek, plasenta, pankreas<\/td><\/tr><tr><td>LDH-5<\/td><td>Karaci\u011fer, iskelet kas\u0131<\/td><\/tr><\/tbody><\/table><\/figure>\n\n<p>Referans bilgileri; kullan\u0131lan y\u00f6ntem, ya\u015f grubu, biyolojik \u00f6rnek tipi ve laboratuvar standard\u0131na g\u00f6re de\u011fi\u015febilece\u011finden, rapor \u00fczerinde yer alan laboratuvar yorumu esas al\u0131nmal\u0131d\u0131r.<\/p>\n<h2>LDH (Laktat Dehidrogenaz), BOS Sonucu Nas\u0131l Yorumlan\u0131r?<\/h2>\n<p>Test sonucu tek ba\u015f\u0131na kesin tan\u0131 koydurmaz. Sonu\u00e7; klinik bulgular, di\u011fer laboratuvar verileri ve gerekli g\u00f6r\u00fcld\u00fc\u011f\u00fcnde ek incelemeler ile birlikte de\u011ferlendirilir.<\/p>\n<h3>Y\u00fcksek LDH<\/h3>\n<p><strong>Hematolojik nedenler:<\/strong><\/p>\n<ul>\n<li>Hemolitik anemiler (belirgin y\u00fckseklik)<\/li>\n<li>Megaloblastik anemi (B12\/folat eksikli\u011fi \u2014 \u00e7ok y\u00fcksek de\u011ferler)<\/li>\n<li>Orak h\u00fccreli anemi<\/li>\n<li>\u0130nefektif eritropoez<\/li>\n<\/ul>\n<p><strong>Malign hastal\u0131klar:<\/strong><\/p>\n<ul>\n<li>Lenfoma (\u00f6zellikle Non-Hodgkin)<\/li>\n<li>L\u00f6semiler<\/li>\n<li>Germ h\u00fccreli t\u00fcm\u00f6rler<\/li>\n<li>Yayg\u0131n metastatik hastal\u0131k<\/li>\n<li>T\u00fcm\u00f6r lizis sendromu<\/li>\n<\/ul>\n<p><strong>Kardiyak:<\/strong><\/p>\n<ul>\n<li>Miyokard enfarkt\u00fcs\u00fc (LDH-1 art\u0131\u015f\u0131; ancak troponin daha spesifiktir)<\/li>\n<\/ul>\n<p><strong>Karaci\u011fer:<\/strong><\/p>\n<ul>\n<li>Hepatit, siroz, karaci\u011fer konjesyonu (LDH-5 art\u0131\u015f\u0131)<\/li>\n<li>\u0130skemik hepatit<\/li>\n<\/ul>\n<p><strong>Di\u011fer:<\/strong><\/p>\n<ul>\n<li>Pulmoner emboli<\/li>\n<li>Kas hastal\u0131klar\u0131, rabdomiyoliz<\/li>\n<li>\u0130nfeksiy\u00f6z monon\u00fckleoz<\/li>\n<li>Pankreatit<\/li>\n<li>Hipotiroidizm<\/li>\n<li>A\u011f\u0131r egzersiz<\/li>\n<\/ul>\n<h3>D\u00fc\u015f\u00fck LDH<\/h3>\n<ul>\n<li>Klinik olarak genellikle \u00f6nemsizdir.<\/li>\n<li>Nadiren genetik LDH eksikli\u011finde g\u00f6r\u00fcl\u00fcr.<\/li>\n<\/ul>\n<p>\u00d6zellikle s\u0131n\u0131rda, d\u00fc\u015f\u00fck d\u00fczeyli veya beklenmeyen sonu\u00e7larda klinik korelasyon gerekir. Gerekti\u011finde tekrar test, panel de\u011ferlendirmesi veya ek laboratuvar incelemeleri planlanabilir.<\/p>\n<h2>Testin S\u0131n\u0131rl\u0131l\u0131klar\u0131<\/h2>\n<p>Her laboratuvar testinde oldu\u011fu gibi bu incelemenin de baz\u0131 s\u0131n\u0131rl\u0131l\u0131klar\u0131 vard\u0131r. Sonu\u00e7; \u00f6rnek kalitesi, \u00f6rnekleme zaman\u0131, ta\u015f\u0131ma ko\u015fullar\u0131 ve klinik ba\u011flamdan etkilenebilir.<\/p>\n<ul>\n<li>Tek bir laboratuvar sonucu, klinik \u00e7er\u00e7eve d\u0131\u015f\u0131nda eksik yorumlanabilir.<\/li>\n<li>Uygun olmayan numune kalitesi sonucun g\u00fcvenilirli\u011fini azaltabilir.<\/li>\n<li>Gerekti\u011finde ek testler olmadan tek ba\u015f\u0131na karar vermek yan\u0131lt\u0131c\u0131 olabilir.<\/li>\n<\/ul>\n<h2>Olas\u0131 Riskler<\/h2>\n<p>Risk \u00e7o\u011funlukla numune alma ve numune y\u00f6netimi s\u00fcreci ile ili\u015fkilidir. Testin kendisinden \u00e7ok, \u00f6rne\u011fin al\u0131nmas\u0131 ve uygun ko\u015fullarda \u00e7al\u0131\u015f\u0131lmas\u0131 \u00f6nem ta\u015f\u0131r.<\/p>\n<ul>\n<li>LDH \u00e7ok spesifik olmayan bir belirte\u00e7tir; hemen her doku hasar\u0131nda y\u00fckselebilir. Tek ba\u015f\u0131na tan\u0131 koydurmaz.<\/li>\n<li>Hemolizli numunelerde LDH yanl\u0131\u015f y\u00fcksek \u00e7\u0131kar (eritrositlerde \u00e7ok y\u00fcksek LDH bulunur). Numune kalitesi kritik \u00f6nem ta\u015f\u0131r.<\/li>\n<li>Trombosit say\u0131s\u0131n\u0131n \u00e7ok y\u00fcksek oldu\u011fu durumlarda da yanl\u0131\u015f y\u00fckseklik g\u00f6r\u00fclebilir.<\/li>\n<li>Malign hastal\u0131klarda prognoz ve tedavi yan\u0131t\u0131 de\u011ferlendirmesinde seri \u00f6l\u00e7\u00fcmler anlaml\u0131d\u0131r.<\/li>\n<li>Hemoliz de\u011ferlendirmesinde LDH, haptoglobin, retik\u00fclosit ve indirekt bilirubin ile birlikte yorumlanmal\u0131d\u0131r.<\/li>\n<li>A\u011f\u0131r egzersiz sonras\u0131 ge\u00e7ici y\u00fckselmeler olabilir.<\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>LDH (Laktat Dehidrogenaz), BOS Laboratuvar Bilgileri Yeni Kod: BIO2389 SUT Kodu: L104930 Eski Kod: B\u01300233 Kategori: Biyokimya Numune T\u00fcr\u00fc: BOS Numune Kab\u0131: Steril Kap \u00c7al\u0131\u015fma G\u00fcn\u00fc: Her g\u00fcn \u00d6nemli Kriter: \u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r. Raporlama Tarihi: Ayn\u0131 g\u00fcn 18:01 LDH (Laktat Dehidrogenaz), BOS Testi Nedir? LDH (Laktat [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":0,"parent":5,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"test_category":"Biyokimya","test_kodu":"BIO2389","numune_turu":"BOS","numune_kabi":"Steril Kap","calisma_gunu":"Her g\u00fcn","onemli_kriter":"\u00c7al\u0131\u015fma g\u00fcn\u00fcnde laboratuvar\u0131m\u0131zda kabul edilen testler, bir sonraki \u00e7al\u0131\u015fma program\u0131nda i\u015fleme al\u0131nacakt\u0131r.","raporlama_tarihi":"Ayn\u0131 g\u00fcn 18:01","numune_red_kriterleri":"","aktarim_kodu":"","loinc_kodu":"","sut_kodu":"L104930","akredite":"","numune_miktari":"","alternatif_ornek":"","numune_alinma_sekli":"","stabilite_ozellikleri":"","calisma_yontemi":"","test_bilgisi":"","footnotes":""},"class_list":["post-2403","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2403","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/types\/page"}],"replies":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/comments?post=2403"}],"version-history":[{"count":4,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2403\/revisions"}],"predecessor-version":[{"id":8860,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/2403\/revisions\/8860"}],"up":[{"embeddable":true,"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/pages\/5"}],"wp:attachment":[{"href":"https:\/\/merkezlaboratuvari.com\/ar\/wp-json\/wp\/v2\/media?parent=2403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}